Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) SHZ

12.00

+0.12(+1.01%)

Updated at December 25 01:15PM

Currency In CNY

Valuation

Market Cap15.69B
Enterprise Value16.97B
P/E Ratio41.52
PEG Ratio11.63
Price/Sales Ratio2.75
Price/Book Ratio1.41
Enterprise/Revenue2.99
Enterprise/EBITDA18.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin-0.05

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue5.26B
Revenue/Share3.67
Gross Profit1.74B
EBITDA1.03B
Net Income646.74M
Diluted EPS0.44

Balance Sheet

Total Cash3.08B
Total Cash/Share2.1
Total Debt3.08B
Total Debt/Equity0.25
Current Ratio2.39
Book Value Per Share8.47

Price History

52-Week Change7.6
52-Week High14.34
52-Week Low9.72
Moving Average 50 Days11.97
Moving Average 200 Days12.01

Statistics

Average Volume3.43M
Shares Outstanding1.25B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.1
Payout Ratio0.17
Last Split Factor8:5
Last Split DateJune 13, 2016